Insider Transactions in Q2 2025 at Akoya Biosciences, Inc. (AKYA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2025
|
Pascal Bamford Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
670
-0.32%
|
$670
$1.25 P/Share
|
|
Apr 01
2025
|
John Frederick Ek CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,432
-6.21%
|
$16,432
$1.35 P/Share
|